Contrary to ACA opponents’ overhyped worries, health care cost growth has fallen through coverage expansions since the late ...
Using the analogy of chess, we suggest tobacco control in the US has reached an endgame phase, during which public health ...
In anticipation of the end of the COVID-19 public health emergency, Congress ended the Medicaid continuous coverage ...
In part 1 of this article, we offered a framework for fit-for-purpose study design and data source selection in the context ...
To support public health efforts and prepare for future pandemics, immunization information systems require long-term ...
This article is the latest in the Health Affairs Forefront series, Provider Prices in the Commercial Sector, featuring analysis and discussion of physician, hospital, and other health care ...
Health Affairs' Editor-in-Chief Alan Weil interviews Avni Gupta of the Commonwealth Fund about her recent paper that explores cost-associated unmet dental, vision, and hearing needs among low ...
The Food and Drug Administration’s approval of nearly a dozen gene therapies in the past year, including milestone treatments for sickle cell disease and hemophilia B, has finally ushered in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback